Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001572736 | SCV001856828 | benign | not provided | 2021-03-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002368594 | SCV002624886 | likely benign | Inborn genetic diseases | 2017-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001572736 | SCV004155337 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | SHANK3: BP4, BP7, BS2 |
Breakthrough Genomics, |
RCV001572736 | SCV005277462 | benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001572736 | SCV001797559 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001701200 | SCV001920395 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001572736 | SCV001967826 | likely benign | not provided | no assertion criteria provided | clinical testing |